Kasturi Vijay 4

What Happened

• Kasturi Vijay, Chief Medical Officer of CG Oncology, received a grant/award (derivative) covering 79,216 shares on 2026-04-15. The reported acquisition price is $0.00, indicating an equity award (option-like instrument) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-15; Form 4 filed 2026-04-16 (timely)
• Reported amount: 79,216 shares; reported price per share: $0.00 (derivative award)
• Vesting: 1/48th of the shares subject to the option vest monthly beginning April 15, 2026, contingent on continuous service through each vesting date (footnote)
• Shares owned after transaction: not specified in the provided filing details
• Transaction code: A (grant/award/other acquisition)

Context

• This was a compensation-related derivative grant (an option-like award) that vests over four years; it is not an open-market purchase or sale and does not reflect an immediate cash outlay or sale of stock. Such grants are common for executive compensation and should be viewed as part of standard equity incentives rather than a direct buy/sell signal.